Archive November 11, 2020 Deciphera Presents Updated Preliminary Data from DCC-3014, its CSF1R Inhibitor Program, in Tenosynovial Giant Cell Tumor Patients at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting
Archive November 10, 2020 Deciphera Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference
Archive November 5, 2020 Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2020 Financial Results
Archive October 28, 2020 Deciphera Pharmaceuticals, Inc. to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 5, 2020
Archive September 18, 2020 Deciphera Presents Data from QINLOCK™ (Ripretinib) Program in Patients with Gastrointestinal Stromal Tumor at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
Archive September 17, 2020 Deciphera Presents Data from Rebastinib, its TIE2 Inhibitor Program, at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
Archive August 17, 2020 Deciphera Announces Publication of QINLOCK™ (ripretinib) Phase 1 Study Results in Patients with Gastrointestinal Stromal Tumor in Journal of Clinical Oncology
Archive August 6, 2020 Deciphera Pharmaceuticals, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
Archive August 4, 2020 Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2020 Financial Results
Archive July 29, 2020 Deciphera Pharmaceuticals, Inc. to Announce Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 4, 2020
